PolyActiva has developed a unique drug-polymer technology that can be used to produce new biomedical products and device components that enable delivery of drugs directly to the affected organ or treatment site, including for example drug-releasing fibres, which bioerode leaving no residue after drug release is complete.

Funding from Commercialisation Australia will help PolyActiva Pty Ltd conduct proof-of-concept trials to demonstrate that the manufacturing processes to produce the drug-releasing fibres is robust and scalable, and meet the performance criteria set by its customers.